Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 18/20 | 0.48 |
| ▸ | ESR1 | P03372 | 6/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4876315 | 0.89 | ESR2 (0.45) | ESR2ESR1CYP3A4CYP2C9KDM4E | |
| SCHEMBL6755897 | 0.81 | ESR2 (0.42) | ESR2ESR1CYP3A4CYP2C9KDM4E | |
| SCHEMBL2718567 | 0.81 | ESR2 (0.41) | ESR2ESR1ALDH1A1 | |
| SCHEMBL2719732 | 0.80 | ALDH1A1 (0.38) | ESR2ESR1MEN1ALDH1A1MAPT | |
| SCHEMBL28794286 | 0.80 | ESR1 (0.52) | ESR2ESR1CYP3A4CYP2C9MEN1 | |
| SCHEMBL10582695 | 0.78 | ESR2 (0.39) | ESR2ESR1CYP3A4CYP2C9ALOX15 | |
| SCHEMBL2718702 | 0.77 | ESR2 (0.40) | ESR2ESR1ALDH1A1 | |
| SCHEMBL4215607 | 0.77 | HSP90AA1 (0.36) | ESR2ALDH1A1LMNA | |
| SCHEMBL21755529 | 0.77 | ESR2 (0.38) | ESR2ESR1CYP3A4CYP2C9ALOX15 | |
| SCHEMBL3809909 | 0.72 | ESR2 (0.81) | ESR2ESR1CYP3A4CYP2C9CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118339201-A | Vinyl compound, method for producing vinyl compound, vinyl composition, vinyl resin cured product, prepreg, resin-coated film, resin-coated metal foil, metal-clad laminate, and printed wiring board | 住友化学株式会社 | 2024-07-12 | — | — | CN | disclosed |
| WO-2023106052-A1 | VINYL COMPOUND, METHOD FOR PRODUCING VINYL COMPOUND, VINYL COMPOSITION, VINYL RESIN CURED PRODUCT, PREPREG, FILM WITH RESIN, METAL FOIL WITH RESIN, METAL-CLAD LAMINATE AND PRINTED WIRING BOARD | 住友化学株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-102234256-B | Novel diepoxide | HONSHU CHEMICAL IND | 2014-12-10 | — | — | CN | disclosed |
| EP-1698625-B1 | EPOXY COMPOUNDS AND CURED EPOXY RESINS OBTAINED BY CURING THE COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2012-10-17 | — | — | EP | disclosed |
| EP-1995245-B1 | METHOD FOR PRODUCING EPOXY COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-20100063182-A1 | EPOXY COMPOSITION | HITACHI, LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-2138521-A1 | EPOXY COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2009-12-30 | — | — | EP | disclosed |
| US-7538166-B2 | Epoxy compounds and cured epoxy resins obtained by curing the compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-05-26 | — | — | US | disclosed |
| US-20090054669-A1 | Process For Producing Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1995245-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20070184280-A1 | Epoxy compounds and cured epoxy resins obtained by curing the compounds | HITACHI, LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1698625-A1 | EPOXY COMPOUNDS AND CURED EPOXY RESINS OBTAINED BY CURING THE COMPOUNDS | Sumitomo Chemical Company, Limited (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054669-A1 | Process For Producing Epoxy Compound | RER1, AR, CYP1A1 | ESR2 4/4885ESR1 11/4885CYP3A4 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.